Article
Overall survival in BRCA-associated ovarian cancer: case-control study of an Italian series.
European journal of gynaecological oncology - 1 Jan 2010
Artioli G, Borgato L, Cappetta A, Wabersich J, Mocellin S, Dalla Palma M, Nicoletto O
Abstract excerpt
About 10% of all ovarian cancers are due to BRCA 1 and/or BRCA 2 mutations. Some studies have shown that patients belonging to this group have a better survival compared to sporadic groups but data are still inconclusive. The aim of this study was to investigate overall survival in patients with ovarian cancer and germ-line mutations in the BRCA1/2 genes in comparison to high-risk patients, defined as patients...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
